MV BioTherapeutics SA

Swiss Biotech Association

Not a member

We are a Swiss microbiome biotherapeutics company with two key platforms:
ApyraVax with the lead indication of Clostridioides difficile infection
ApyraMed with lead indications as Cancer Immunotherapy Enhancer and Dysbiosis

https://www.mv-bio.com/

Location

Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2018
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Laevoroc Oncology AG

Founded in 2019, Laevoroc is a privately-owned, Swiss oncology group of companies that leverages word-class technologies, our oncology expertise and extensive R&D and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary.
Hünenberg

Member

Rowestil Consulting GmbH

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
6318 Walchwil

Member

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
6850 Mendrisio

Member